×
Beauty Health Operating Expenses 2020-2024 | SKIN
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Revenue
Gross Profit
Operating Income
EBITDA
Net Income
EPS
Shares Outstanding
Beauty Health operating expenses from 2020 to 2024. Operating expenses can be defined as the sum of all operating expenses for the given industry.
View More
Beauty Health Operating Expenses 2020-2024 | SKIN
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Revenue
Gross Profit
Operating Income
EBITDA
Net Income
EPS
Shares Outstanding
Beauty Health operating expenses from 2020 to 2024. Operating expenses can be defined as the sum of all operating expenses for the given industry.
Related Stocks
Company Name
Market
Cap
Elevance Health (ELV)
$88.4B
Cencora (COR)
$45.7B
Natera (NTRA)
$23.1B
DiDi Global (DIDIY)
$22B
ICON (ICLR)
$18B
Avantor (AVTR)
$14.7B
Viatris (VTRS)
$13.9B
Revvity (RVTY)
$13.9B
BioMerieux (BMXMF)
$12.6B
CochLear (CHEOY)
$12.1B
Solventum (SOLV)
$11.6B
Medpace Holdings (MEDP)
$10.9B
Doximity (DOCS)
$9.7B
EUROFINS SCIENT (ERFSF)
$9.7B
Charles River Laboratories (CRL)
$9.5B
HealthEquity (HQY)
$8.7B
Sonic Healthcare (SKHHY)
$8.2B
Bausch + Lomb (BLCO)
$6.3B
Amplifon S.p.A (AMFPF)
$5.9B
Organon (OGN)
$4.1B
Sotera Health (SHC)
$3.7B
BrightSpring Health Services (BTSG)
$3B
Surgery Partners (SGRY)
$2.6B
Concentras Parent (CON)
$2.5B
GeneDx Holdings (WGS)
$2.5B
Alignment Healthcare (ALHC)
$2.3B
Ardent Health Partners (ARDT)
$2.3B
Premier (PINC)
$2B
PACS (PACS)
$2B
GoodRx Holdings (GDRX)
$1.7B